Clinical Trial

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 29, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to systematically characterize the gut microbiota of various critical chronic diseases, compare the similarities and differences of the microbiome signatures linked to different regions and diseases, and further investigate their impacts on microbiota-based diagnostic models.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05638269
Lead Sponsor Zhujiang Hospital
Collaborators: National Natural Science Foundation of China
Conditions Essential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer, Lung Cancer, Chronic Kidney Diseases, Acute Coronary Syndrome, Epilepsy +3 more
Enrollment 12,000 participants
Start Date 2022-03-01
Primary Completion 2024-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-29